Stem Cells In Wound Healing With Integra as a Carrier

Trial Profile

Stem Cells In Wound Healing With Integra as a Carrier

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 22 Aug 2016

At a glance

  • Drugs Adipose stem cell therapy Anterogen (Primary) ; Amniotic cell therapy-NuCel (Primary)
  • Indications Wounds
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 May 2015 Status changed from not yet recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
    • 30 Dec 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top